CRRTF
Price:
$0.449
Market Cap:
$12.02M
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination wit...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-04-11
Stock Exchange
PNK
Ticker
CRRTF
According to Crescita Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.08. This represents a change of -20.34% compared to the average of -5.12 of the last 4 quarters.
The mean historical PE Ratio of Crescita Therapeutics Inc. over the last ten years is 39.90. The current -4.08 PE Ratio has changed -1122.54% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's PE Ratio was at its highest in in the March 2019 quarter at 87.06. The PE Ratio was at its lowest in in the June 2022 quarter at -97.76.
Average
39.90
Median
-0.78
Minimum
-12.05
Maximum
387.86
Discovering the peaks and valleys of Crescita Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.45%
Maximum Annual PE Ratio = 387.86
Minimum Annual Increase = -743.14%
Minimum Annual PE Ratio = -12.05
Year | PE Ratio | Change |
---|---|---|
2023 | -3.78 | -124.21% |
2022 | 15.61 | -229.54% |
2021 | -12.05 | -103.11% |
2020 | 387.86 | 3.45% |
2019 | 10.93 | 168.69% |
2018 | 4.07 | -743.14% |
2017 | -0.63 | -33.94% |
2016 | -0.96 | -14.86% |
2015 | -1.12 | 22.58% |
The current PE Ratio of Crescita Therapeutics Inc. (CRRTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.07
5-year avg
79.71
10-year avg
39.90
Crescita Therapeutics Inc.’s PE Ratio is less than Amexdrug Corporation (216.50), less than The BC Bud Corporation (-0.18), less than Aspen Pharmacare Holdings Limited (14.48), greater than Antisense Therapeutics Limited (-6.27), less than Cipher Pharmaceuticals Inc. (11.66), less than Cannara Biotech Inc. (12.60), greater than Knight Therapeutics Inc. (-26.90), less than Lowell Farms Inc. (-0.01), less than Canntab Therapeutics Limited (-0.00), greater than Bionoid Pharma Inc. (-507.70), less than HLS Therapeutics Inc. (-3.29), less than CENTR Brands Corp. (-1.38), less than RAMM Pharma Corp. (0), less than Craftport Cannabis Corp. (-0.01), less than Speakeasy Cannabis Club Ltd. (-0.00), less than City View Green Holdings Inc. (-1.54), less than RavenQuest BioMed Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
216.50 | $338.82K | |
-0.18 | $781.33K | |
14.48 | $5.44B | |
-6.27 | $92.64M | |
11.66 | $279.69M | |
12.60 | $48.02M | |
-26.90 | $407.94M | |
-0.01 | $292.10K | |
-0.00 | $147.02K | |
-507.70 | $12.19M | |
-3.29 | $79.48M | |
-1.38 | $3.47M | |
0 | $15.16M | |
-0.01 | $6.48B | |
-0.00 | $1.31K | |
-1.54 | $1.92M | |
-0.00 | $482.11K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Crescita Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Crescita Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Crescita Therapeutics Inc. (CRRTF)?
What is the highest PE Ratio for Crescita Therapeutics Inc. (CRRTF)?
What is the 3-year average PE Ratio for Crescita Therapeutics Inc. (CRRTF)?
What is the 5-year average PE Ratio for Crescita Therapeutics Inc. (CRRTF)?
How does the current PE Ratio for Crescita Therapeutics Inc. (CRRTF) compare to its historical average?